Teva Pharmaceutical Industries Limited
NYSE:TEVA · New York Stock Exchange
-$1.09 today
Vol 10.00M · Avg 6.22M
Filings
Ground the analysis in primary documents
Pair price history with recent company filings so you can connect market moves to the actual disclosures behind the business.
Price History
Dividend-adjusted closing price
Change
+85.50%
Period High
$36.34
Period Low
$15.38
Latest
$31.48
SEC Filings
Recent regulatory filings
No filings found.
Competitors
Peer companies in the same sector
Natera, Inc.
NASDAQ:NTRA
$32.78B
Biogen Inc.
NASDAQ:BIIB
$28.96B
DexCom, Inc.
NASDAQ:DXCM
$27.83B
Koninklijke Philips N.V.
NYSE:PHG
$26.01B
Waters Corporation
NYSE:WAT
$23.24B
BioNTech SE
NASDAQ:BNTX
$23.08B
Labcorp Holdings Inc.
NYSE:LH
$20.96B
STERIS plc
NYSE:STE
$19.68B
Neurocrine Biosciences, Inc.
NASDAQ:NBIX
$15.80B
Insulet Corporation
NASDAQ:PODD
$9.99B
What is the latest TEVA filing?
The latest filing shown is 4 dated Jun 16, 2026.
How many recent filings does TEVA have?
Intrinsic Alpha currently shows 20 recent filings for TEVA.
Explore More
Continue the stock analysis
Jump to another research area for this company.